MOA Flashcards

(39 cards)

1
Q

Thioamides- PTU and MMI

A

Prevent hormone synthesis by inhibiting TPO-catalyzed rxns to block iodide organification

Block coupling of iodotyrosines

Drug binds to and inactivates TPO

Slow onset (takes 4- wks to deplete), excreted in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anion Inhibitors- ClO4- and TeO4-

A

Compete with sodium ion transporter for uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Iodide

A

Inhibit organification and hormone release and ↓ size of hyper plastic gland

Effect reverses with time (escape) if used alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Radioactive Iodine

I131

A

Taken orally → rapidly
concentrated in thyroid follicle cells, where
β particles selectively destroy gland w/o injury to adjacent cells →
become euthyroid in 6-8 wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Biguanides

A

Enhances effects of insulin “sensitizer”

Activates AMP-dependent protein kinase (AMPK) causing ↑ glucose uptake by fat and muscle and ↓ production by liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sulfonylureas

A

↑ Insulin release from pancreas beta cells by binding to K+ channel (requires functional beta cells)

Mimic Glucose to Close ATP-sensitive K+ Channels and Stimulate Insulin Secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-Sulfonylurea Secretagogues (Meglitinides)

A

Mimic glucose to close K+ ch and stim insulin secretion

↑ Insulin release from pancreas beta cells by bindi to beta K+ cells (require fn beta cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thiazolidenediones (TZDs)

A

↑ Insulin sensitivity in target tissues by activating receptor gamma (PPAR-gamma) liganda

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GLP-1 Receptor Agonists

A

↑ glucose-dependent insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

A

Prolong endogenous GLP-1 action

↑ glucose-mediated insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

α-Glucosidase Inhibitors

A

Stays in intestine and ↓ GI glucose absorption

↓ Postprandial glycemia (must be taken with meal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Canagliflozin

A

Glucose co-transporter inhibitor

Inhibition of SGLT-2 → suppresses renal glucose re-absorption → lowers blood glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Estrogen/progestin combo pill

A

Hypothal
↓ GnRH pulses (P) → no LH surge

Pituitaty
↓ responsiveness to GnRH (combo)

↓FSH/LH release (E) → ↓ follicular devel

Other
thickening of cervical mucus (P) → ↓ sperm penetration

Atrophic endometrium ( P) to implantation

↓ transport of sperm/egg through fallopian tub (combo)

Overall blocks ovulation, atrophies endometrium, thick cervical mucus, altered traans in fallopian tube

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ulipristal

A

Selective

Delays ovulation

Alters cervical mucus and endometrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mifepristone

RU486

A

Competitive antagonist

Blocks uterine progesterone receptors → decidual breakdown → blastocyst detachment (↓hCG)

↑ sensitivity of myometrium to PG → contractile, softens cervix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Generally how do combo estrogen/progestins work?

A

by suppressing follicle development, thickening cervical mucus, and inhibiting ovulation

17
Q

Copper IUD

A

reduces sperm motility and viability

18
Q

LNG-IUD

A

inhibits ovulation, thickens cervical mucus, reduces sperm motility and viability

19
Q

Hormonal EC

A

acts by delaying ovulation and may also interfere with sperm migration and fn at all levels of genital tract

20
Q

Tamoxifen

A

Metabolized by CYP2D6 to active metabolites endoxifen and 4- hydroxyTAM that bind to ER-alpha, acting as antagonists in breast tissue to inhibit gene transcription, inhibit cell proliferation and promote apoptosis

Acts as a partial agonist in endometrium to promote endometrial hyperplasia

21
Q

Toremifene

A

Active antagonist at ER-alpha/beta

Does NOT require activation by CYP2D6

Insufficient clinical data at this time, but may act as partial agonist in endometrium to promote endometrial cancer

22
Q

Leuprolide

A

Disrupts normal pulsatile stimulation of GnRH receptor by endogenous GnRH
→ desensitization of GnRH receptor in the pituitary→ ↓ release of FSH and LH from the pituitary→ ↓ estrogen synthesis in the ovaries

23
Q

Anastrozole

A

Reversible inhibitor

Prevent conversion of testosterone to estrogen by inhibiting aromatase (CYP19A1) in adipose tissue

24
Q

Exemestane

A

Suicide inhibitor

Prevent conversion of testosterone to estrogen by inhibiting aromatase (CYP19A1) in adipose tissue

25
Trastuzumab
“Armed” monoclonal Ab that has been coupled with DM1 (emtansine) Ab binds to HER2 extracellular domain IV → Ab is internalized into lysosomal stores → DM1 is released DM1 is a mitotic spindle poison, binds beta-tubulin to inhibit microtubule polymerization
26
Pertuzumab
Monoclonal Ab binds HER2 extracellular domain II to prevent ligand-dependent dimerization with EGFR
27
ALKYLATING AGENTS (Cyclophosphamide and Cisplatin)
CCNS drugs Greatest anti-ca activity in S phase Bi-functional Alkylates guanine residues → produces interstrand crosslinks Guanine has abnrml base-pairing w/ thymine during replication → protein miscoding and apoptosis
28
ANTI-METABOLITES
CCS drugs (active in S-phase of cell cycle) Structurally similar to endogenous molecules → act as antagonists of biosynthetic pthwys Ca cells are more sensitive than nrml cells bc of high growth fraction and higher levels of certain enzymes
29
Methotrexate
CCS Folic acid analog ``` Binds to and inhibits DHFR → prevents formation of THF from folate → prevents thymidylate, purine & amino acid synthesis→ interruption of DNA, RNA and protein syntheses ```
30
5-Fluorouracil
CCS Analog of uracil Prodrug → converted to 5FdUMP, which inhibits TS activity which is required for de novo pyrimidine synthesis → slows ca cell replication and causes DNA damage
31
6-Mercaptopurine
CCS HGPRT metabolizes 6 mercap into TIMP → converted to Thio-dGTP Thio-dGTP is incorporated into DNA of replicating cancer cells→ leading to apoptosis
32
Vinca Alkaloids (Vinblastine and Vincristine)
Binds to β-tubulin→ prevents polymerization of microtubules → causes blocking of mitotic spindle formation → tumor cell death
33
Paclitaxel
CCS Binds with high affinity to β-tubulin and stabilizes microtubules (prevents depolymerization)→ cells blocked at G2/M phase
34
Etoposide
CCS Inhibits topoisomerase II → prevents DNA uncoiling → DNA strand breakage
35
Irinotecan
CCS (CCNS at higher concentration) Inhibits topoisomerase I → prevents uncoiling → DNA strand breakage
36
ANTIBIOTICS
Insert btwn base pairs of DNA → Δ DNA configuration → strand breakage/ enzyme interference
37
Doxorubicin
CCNS DNA intercalation that interferes with DNA & RNA synthesis Inhibits topoisomerase II→ DNA fragmentation Free radical formation → DNA scission (responsible for cardiotox)
38
Bleomycin
CCS ``` Intercalation, scission and fragmentation of DNA due to oxidation by a DNAbleomycin-Fe(II) complex ```
39
Allopurinol
Inhibits XO → prevent uric acid production